Viewing Study NCT04965766


Ignite Creation Date: 2025-12-24 @ 4:11 PM
Ignite Modification Date: 2025-12-26 @ 8:55 AM
Study NCT ID: NCT04965766
Status: RECRUITING
Last Update Posted: 2025-12-23
First Post: 2021-06-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Patritumab Deruxtecan (U3-1402) in Unresectable Locally Advanced or Metastatic Breast Cancer
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module